News | Ultrasound Women's Health | January 30, 2019

QTbreasthealth Opens New Breast Ultrasound Imaging Center in Grand Rapids

FDA-approved breast ultrasound system provides radiation-free 3-D imaging for secondary screening

QTbreasthealth Opens New Breast Ultrasound Imaging Center in Grand Rapids

January 30, 2019 — QTbreasthealth launched a center in Grand Rapids, Mich., featuring its quantitative transmission ultrasound technology known as the QTscan. The U.S. Food and Drug Administration (FDA)-cleared 3-D ultrasound breast imaging technology provides women an option with no radiation, no compression and no injections. It also provides unimpeded visibility for women with dense breast tissue. QTbreasthealth’s goal is to provide technology that encourages women to get scanned as often as necessary, with no risk.

The Grand Rapids center is the third QTbreasthealth location, following two California locations in Marin and Walnut Creek, with several more locations scheduled to open around the country throughout 2019. News of the Grand Rapids opening comes on the heels of ongoing clinical trials, which have found the QTscan to be successful in identifying various types of breast tissue, particularly within dense breasts.

The new Grand Rapids center, like all QTbreasthealth locations, offers a spa-like breast imaging experience, complete with soothing scents, comforting robes and a relaxing imaging scan that some women actually sleep through. Unlike most other breast imaging centers, QTbreasthealth patients receive results via phone or teleconference with a provider within 72 hours.

Because the QTscan uses no radiation, the exam is available to women of all ages and avoids the frequency limits associated with radiation-based imaging tests. The clear and comprehensive, 3-D image delivered by the QTscan also makes QTbreasthealth an ideal second opinion for breast imaging, providing a more detailed image than mammography or handheld ultrasound.

For more information: www.qtultrasound.com

Related Content

IBM collected a dataset of 52,936 images from 13,234 women who underwent at least one mammogram between 2013 and 2017.

IBM collected a dataset of 52,936 images from 13,234 women who underwent at least one mammogram between 2013 and 2017, and who had health records for at least one year prior to the mammogram. The algorithm was trained on 9,611 mammograms. Image courtesy of Radiology.

Feature | Artificial Intelligence | July 19, 2019 | Michal Chorev
Breast cancer is the global leading cause of cancer-related deaths in women, and the most commonly diagnosed cancer...
Paragon Biosciences Launches Qlarity Imaging to Advance FDA-cleared AI Breast Cancer Diagnosis System

Qlarity Imaging’s software is used to assist radiologists in the assessment and characterization of breast lesions. Imaging features are synthesized by an artificial intelligence algorithm into a single value, the QI score, which is analyzed relative to a database of reference abnormalities with known ground truth. Image courtesy of Business Wire.

Technology | Artificial Intelligence | July 18, 2019
Paragon Biosciences LLC announced the launch of its seventh portfolio company, Qlarity Imaging LLC, which was founded...
FDA Clears Koios DS Breast 2.0 AI-based Software
News | Ultrasound Women's Health | July 11, 2019
Koios Medical announced its second 510(k) clearance from the U.S. Food and Drug Administration (FDA).
360 Photos | Ultrasound Imaging | July 11, 2019
This 360 degree photo shows a basic, point-of-care cardiac echocardiogram being performed using a smartphone turned i
SimonMed Imaging Implements ProFound AI for 3-D Tomosynthesis
News | Mammography | July 10, 2019
Arizona-based SimonMed Imaging announced their implementation of the first U.S. Food and Drug Administration (FDA)-...
360 Photos | Ultrasound Imaging | July 09, 2019
A view of a mitral valve on a GE Healthcare Vivid E95 ...
360 Photos | Ultrasound Imaging | July 08, 2019
This is a 360 degree view of a live cardiac echo demonstration for the Siemens Healthineers Acuson SC2000...
Therapixel Appoints Matthieu Leclerc-Chalvet as CEO
News | Artificial Intelligence | July 03, 2019
Artificial intelligence (AI) breast cancer screening specialist Therapixel announced the appointment of Matthieu...
GE Healthcare showcases Senographe Pristina Serena featuring its add-on-biopsy kit at the Breast Imaging Symposium. Photo by Greg Freiherr

GE Healthcare showcases Senographe Pristina Serena featuring its add-on-biopsy kit at the Breast Imaging Symposium. Photo by Greg Freiherr

Feature | Breast Imaging | July 03, 2019 | By Greg Freiherr
Productivity and its enabler — efficiency — guided the display of products at the April...
Countless possibilities can impact the future of global healthcare and AI is the first step toward breakthrough that will change the landscape of personalized medicine
Feature | Women's Health | July 03, 2019 | By Samir Parikh
Contrary to what many people believe,...